Skip to main content

Mayo Clinic

SEC CIK
0001318153
Latest filing
Nov 12, 2024

Holdings in Q4 2023

Holdings as of Dec 31, 2023, filed Feb 13, 2024. Long positions only; changes compare share counts with Q3 2023.

Institution overview
Positions
7
−2 vs. Q3 2023
Portfolio value
$16.2M
−$35.7M (−68.8%) vs. Q3 2023
Filed
Feb 13, 2024
SEC
Holdings of Mayo Clinic in Q4 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
iShares Tr464288257MSCI ACWI ETF113,737$11.6M71.5%−365,199−76.3%Reduced–
ZNTLZentalis Pharmaceuticals, Inc.COM187,143$2.84M17.5%00.0%UnchangedHistory
IMNMImmunome Inc.COM108,480$1.16M7.2%+108,480NewHistory
NMTCNeuroone Medical Technologies CorpCOM NEW181,754$287.2K1.8%00.0%UnchangedHistory
UBXUnity Biotechnology, Inc.COM124,081$239.5K1.5%00.0%UnchangedHistory
SCLXScilex Holding CoCOM42,303$86.3K0.5%00.0%UnchangedHistory
IBRXImmunityBio, Inc.COM1,403$7.04K<0.1%+1,403NewHistory

Sold out since Q3 2023 (4)

Positions held at the end of Q3 2023 that are gone from this filing.

Positions of Mayo Clinic sold out since Q3 2023
SecurityClassShares in Q3 2023Value in Q3 2023% of portfolio in Q3 2023History
BSMBlack Stone Minerals, L.P.COM UNIT166,147$2.86M5.5%History
MIROMiromatrix Medical Inc.COM191,622$251.0K0.5%History
CLPTClearPoint Neuro, Inc.COM38,114$191.0K0.4%History
EVLOEvelo Biosciences, Inc.COM22,577$88.5K0.2%History